Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPOP: 17P to reduce preterm birth in HIV+ women
NCT03297216Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2018
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyprogesterone caproate in preterm birth, stillbirth, sponsored by University of North Carolina at Chapel Hill. Started Feb 2018; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birthstillbirth
Beyond the preview
Go deeper on NCT03297216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297216.